Clinical Efficacy of Soft Tissue Trimmer in Cases of Gingival Hyperplasia.

NCT ID: NCT04542486

Last Updated: 2022-04-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

28 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-28

Study Completion Date

2021-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Postoperative pain and wound healing are compared after using conventional scalpel technique in comparison with the intervention which is using Soft tissue Trimmer for cases of gingival hyperplasia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the control group:

1. Following the local anaesthetic administration, A reverse bevel gingivectomy will be performed with a #15c scalpel.
2. The borderline of gingiva will be determined via the use of a pointer dental tweezers, and excessive gingival tissue will then be removed with Gracey curettes
3. No periodontal packs to be applied to ensure accurate evaluations of follow-up pain and wound healing

In the intervention group:

1. Following the local anaesthetics administration for the Soft tissue trimmer(STT) gingivectomies, Soft tissue trimmer will be used with 400-rpm rotary systems and with no serum irrigation, per the manufacturer's recommendation.
2. Gingivoplasties will be performed with the same Soft tissue trimmer to easily provide a knife-edge appearance.
3. No periodontal packs will be applied to ensure accurate evaluations of follow-up pain and wound healing.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain, Postoperative Wound Heal Gingival Hyperplasia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

The conventional approach:

Gingivoplasties and removal of excess gingival tissues through the conventional scalpel technique using a reverse bevel.

Group Type EXPERIMENTAL

Excision of gingival hyperplasia using the conventional scalpel technique

Intervention Type PROCEDURE

Excision of gingival hyperplasia in gingivoplasties using the conventional technique reverse bevel using 15c blade.

The intervention approach:

Gingivoplasties and elimination of excess gingival tissues through the use of "Soft tissue trimmer".

Group Type ACTIVE_COMPARATOR

Excision of gingival hyperplasia using "Soft tissue trimmer ".

Intervention Type PROCEDURE

Gingivoplasties and removal of excess gingival tissues using Soft tissue trimmer.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Excision of gingival hyperplasia using "Soft tissue trimmer ".

Gingivoplasties and removal of excess gingival tissues using Soft tissue trimmer.

Intervention Type PROCEDURE

Excision of gingival hyperplasia using the conventional scalpel technique

Excision of gingival hyperplasia in gingivoplasties using the conventional technique reverse bevel using 15c blade.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Anterior region (minimum of four teeth at each surgical site)
* Age range (18-45) years old
* Plaque-induced inflammatory gingival enlargement
* Altered passive eruption
* No clinical attachment loss
* Systemically healthy individuals

Exclusion Criteria

* Gingival enlargement due to any systemic predisposing factors
* Pregnancy and/or lactation
* Allergy
* Conditions requiring antibiotic prophylaxis and anti-inflammatory medications.
* Acute or untreated periodontitis
* Systemic disease that could influence the outcome of the treatment (i.e. Diabetes)
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mai Mohamed Sameh

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Oral and Dental Medicine-CU

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PER 3-3-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.